| 1 |
Kathleen Meier-Hellstern |
AT&T |
5 |
| 2 |
Yuanqiu Luo |
Futurewei Technologies |
4 |
| 2 |
Lalit Dhawan |
Bank of America |
4 |
| #4 |
Kenneth Ellsworth |
Merck |
3 |
| #4 |
Jeffrey Loprete |
Automatic Switch |
3 |
| #4 |
Philip Nan Ji |
Nec |
3 |
| #4 |
Hong Xian Li |
Cj Cheiljedang |
3 |
| #8 |
Li Xiao |
Merck |
2 |
| #8 |
Shubh D. Sharma |
Palatin Technologies |
2 |
| #8 |
Zeenat Nabi |
Colgate-Palmolive |
2 |
| #8 |
Wen-Hwa Ting Li |
Johnson & Johnson |
2 |
| #8 |
Randell L. Mills |
Brilliant Light Power |
2 |
| #13 |
Edna Ambundo |
Colgate-Palmolive |
1 |
| #13 |
Archana Mukhopadhyay |
University of Florida |
1 |
| #13 |
Steven Tuske |
Amicus Therapeutics |
1 |
| #13 |
Carmine Bucalo |
Mars, Incorporated |
1 |
| #13 |
Karen L. Ehrenworth |
Verizon |
1 |
| #13 |
Gareth Funka-Lea |
Siemens Aktiengesellschaft |
1 |
| #13 |
Maria Taddei |
— |
1 |
| #13 |
Roger Jones |
Innate Tumor Immunity |
1 |
| #13 |
Ce Feng Liu |
Amicus Therapeutics |
1 |
| #13 |
Ronald Harning |
Sun Pharma Advanced Research Company |
1 |
| #13 |
Hiten GUTKA |
— |
1 |
| #13 |
Gregory Pulz |
AT&T |
1 |
| #13 |
Harold Y. Hwang |
MIT |
1 |
| #13 |
Richard Hellstern |
AT&T |
1 |
| #13 |
Alan Sorrentino |
— |
1 |
| #13 |
Benjamin D. Benattar |
Stages |
1 |
| #13 |
Lingang Foung |
— |
1 |
| #13 |
Jessica CHEUNG |
— |
1 |
| #13 |
Frances M Stewart |
— |
1 |
| #13 |
Zheqiong Wu |
Bantam Pharmaceutical |
1 |
| #13 |
Jamie R. Wisser |
— |
1 |
| #13 |
Srinivasan Vairavan |
Koniniklijke Philips N.V. |
1 |
| #13 |
Andrew G. Cole |
Ligand Pharmaceuticals Incorporated |
1 |
| #13 |
Xiao Ming Mai |
Unknown |
1 |